Test Price
650 AED✅ Home Collection Available
Ovarian Cancer Panel in UAE | 650 AED DHA Approved
Executive Summary & Core Metrics
The Ovarian Cancer Panel is a high-precision blood test measuring key tumour biomarkers including CA-125, HE4, and the ROMA index, utilizing advanced CMIA and ELISA immunoassays. This test delivers 99.9% diagnostic sensitivity through ISO-accredited processing at DNA Labs UAE, a DHA-licensed facility (License No. 1143) in Dubai Healthcare City.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Result Interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Ovarian Cancer Panel employs chemiluminescent microparticle immunoassay (CMIA) and enzyme-linked immunosorbent assay (ELISA) to quantitatively measure CA-125, HE4, and compute the ROMA index. This multi-marker approach provides superior diagnostic accuracy compared to single-marker testing, enabling differentiation between benign and malignant pelvic masses.
| Feature | DNA Labs UAE Ovarian Cancer Panel | Standard Alternative |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity (CMIA/ELISA) | Moderate sensitivity, single-marker approach |
| Methodology | CMIA & ELISA (CLIA-grade) | Conventional ELISA or manual assays |
| Turnaround Time | Same-day reporting (samples received by 9:00 AM) | 24 – 48 hours |
Physician Insight & Safety Protocols
“As a specialist in diagnostic radiology, I emphasize that tumour marker results must always be correlated with clinical symptoms and imaging findings. An elevated biomarker level does not independently confirm malignancy, just as a normal range does not definitively exclude disease. Comprehensive clinical evaluation remains essential for accurate diagnosis and management.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication Advisory
⚠ Important Safety Information
- Do not discontinue prescribed medication without consulting your treating physician.
- Patients on high-dose biotin supplements must pause supplementation 24 hours before blood sampling.
- This test is not indicated for emergency diagnosis or acute management decisions.
Exclusion Criteria & Warning Signs
- ER Red Flags: Seek immediate medical attention if you experience sudden severe pelvic pain, acute abdominal bloating, or abnormal vaginal bleeding.
- Exclusion: Results should not be used as a standalone diagnostic tool; imaging and clinical correlation are mandatory.
Patient FAQ & Clinical Guidance
1. What markers are measured in the Ovarian Cancer Panel?
The panel quantifies CA-125, HE4, and calculates the ROMA index to differentiate benign from malignant pelvic masses using high-sensitivity chemiluminescent immunoassay (CMIA).
2. How should I prepare for the blood draw?
No fasting or special preparation is required. Simply avoid high-dose biotin supplements for 24 hours prior to sampling and continue all prescribed medications unless advised otherwise by your physician.
3. When will I receive my results and can a doctor explain them?
Results are released the same day when the sample reaches the laboratory by 9:00 AM. You will receive a complimentary telephonic consultation with a DHA-licensed physician to interpret the clinical findings and guide next steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing patient data privacy and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability ensuring patient safety and informed consent protocols. All laboratory processes are performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). Your data privacy is guaranteed.
Clinical & Logistical Metadata
| Test Name | Ovarian Cancer Panel (CA-125, HE4, ROMA Index) |
| Price (AED) | 650 AED |
| Turnaround Time | Same-day reporting (samples received by 9:00 AM) |
| Sample Type / Matrix | Blood (Serum/Plasma) |
| Methodology Used | CMIA (Chemiluminescent Microparticle Immunoassay) & ELISA |
| ICD-10-CM Code | C56, Z12.73 |
| LOINC Code | 10383-7 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians